Back to mobile site

Jefferies Says Dynavax (DVAX) Should Be Bought on Weakness

March 4, 2013 10:25 AM EST Send to a Friend
Jefferies reiterated its Buy rating and $5 price target on Dynavax Technologies (NASDAQ: DVAX) following Q4 results saying the stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login